Genetic discoveries as the basis of personalized therapy: rosiglitazone treatment of Alzheimer's disease

被引：8

作者：

Hsueh, W. ^{[1
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Endocrinol Diabet & Hypertens, Los Angeles, CA 90024 USA

来源：

PHARMACOGENOMICS JOURNAL | 2006年 / 6卷 / 04期

关键词：

D O I：

10.1038/sj.tpj.6500383

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

[No abstract available]

引用

页码：222 / 224

页数：3

共 29 条

[11] Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study [J].

Kuusisto, J ;

Koivisto, K ;

Mykkanen, L ;

Helkala, EL ;

Vanhanen, M ;

Hanninen, T ;

Kervinen, K ;

Kesaniemi, YA ;

Riekkinen, PJ ;

Laakso, M .

BRITISH MEDICAL JOURNAL, 1997, 315 (7115) :1045-1049

[12] Rosiglitazone monotherapy is effective in patients with type 2 diabetes [J].

Lebovitz, HE ;

Dole, JF ;

Patwardhan, R ;

Rappaport, EB ;

Freed, MI .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (01) :280-288

[13] AN ANTIDIABETIC THIAZOLIDINEDIONE IS A HIGH-AFFINITY LIGAND FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA(PPAR-GAMMA) [J].

LEHMANN, JM ;

MOORE, LB ;

SMITHOLIVER, TA ;

WILKISON, WO ;

WILLSON, TM ;

KLIEWER, SA .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) :12953-12956

[14] Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death [J].

Leissring, MA ;

Farris, W ;

Chang, AY ;

Walsh, DM ;

Wu, XN ;

Sun, XY ;

Frosch, MP ;

Selkoe, DJ .

NEURON, 2003, 40 (06) :1087-1093

[15] Activation of peroxisome proliferator-activated receptor-γ by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3′-kinase-dependent pathway [J].

Lin, CY ;

Gurlo, T ;

Haataja, L ;

Hsueh, WA ;

Butler, PC .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (12) :6678-6686

[16] Response of experimental retinal neovascularization to thiazolidinediones [J].

Murata, T ;

Hata, Y ;

Ishibashi, T ;

Kim, S ;

Hsueh, WA ;

Law, RE ;

Hinton, DR .

ARCHIVES OF OPHTHALMOLOGY, 2001, 119 (05) :709-717

[17] Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline [J].

Näslund, J ;

Haroutunian, V ;

Mohs, R ;

Davis, KL ;

Davies, P ;

Greengard, P ;

Buxbaum, JD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (12) :1571-1577

[18] Translational research on the way to effective therapy for Alzheimer disease [J].

Rosenberg, RN .

ARCHIVES OF GENERAL PSYCHIATRY, 2005, 62 (11) :1186-1192

[19] The molecular and genetic basis of AD: The end of the beginning - The 2000 Wartenberg lecture [J].

Rosenberg, RN .

NEUROLOGY, 2000, 54 (11) :2045-2054

[20] AMYLOID PEPTIDES ARE TOXIC VIA A COMMON OXIDATIVE MECHANISM [J].

SCHUBERT, D ;

BEHL, C ;

LESLEY, R ;

BRACK, A ;

DARGUSCH, R ;

SAGARA, Y ;

KIMURA, H .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (06) :1989-1993

← 1 2 3 →